Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability

The formulation of biopharmaceutical drugs is designed to eliminate chemical instabilities, increase conformational and colloidal stability of proteins, and optimize interfacial stability. Among the various excipients involved, buffer composition plays a pivotal role. However, conventional buffers l...

Full description

Saved in:
Bibliographic Details
Main Authors: Lebar Blaž, Zidar Mitja, Mravljak Janez, Šink Roman, Žula Aleš, Pajk Stane
Format: Article
Language:English
Published: Sciendo 2024-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2024-0022
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572726508781568
author Lebar Blaž
Zidar Mitja
Mravljak Janez
Šink Roman
Žula Aleš
Pajk Stane
author_facet Lebar Blaž
Zidar Mitja
Mravljak Janez
Šink Roman
Žula Aleš
Pajk Stane
author_sort Lebar Blaž
collection DOAJ
description The formulation of biopharmaceutical drugs is designed to eliminate chemical instabilities, increase conformational and colloidal stability of proteins, and optimize interfacial stability. Among the various excipients involved, buffer composition plays a pivotal role. However, conventional buffers like histidine and phosphate buffers may not always be the optimal choice for all monoclonal antibodies (mAbs). In this study, we investigated the effects of several alternative buffer systems on seven different mAbs, exploring various combinations of ionic strengths, concentrations of the main buffer component, mAb concentrations, and stress conditions. Protein stability was assessed by analyzing soluble aggregate formation through size exclusion chromatography. At low protein concentrations, protein instability after temperature stress was exclusively observed in the bis-TRIS/ glucuronate buffer. Conversely, freeze-thaw stress led to a significant increase in aggregate formation in tested formulations, highlighting the efficacy of several alternative buffers, particularly arginine/ citrate, in preserving protein stability. Under temperature stress, the introduction of arginine to histidine buffer systems provided additional stabilization, while the addition of lysine resulted in protein destabilization. Similarly, the incorporation of arginine into histi-dine/HCl buffer further enhanced protein stability during freeze--thaw cycles. At high protein concentrations, the histidine/citrate buffer emerged as one of the most optimal choices for addressing temperature and light-induced stress. The efficacy of histidine buffers in combating light stress might be attributed to the light-absorbing properties of histidine molecules. Our findings demonstrate that the development of biopharmaceutical formulations should not be confined to conventional buffer systems, as numerous alternative options exhibit comparable or even superior performance.
format Article
id doaj-art-f62cd29e0f684705b3c342fb13655542
institution Kabale University
issn 1846-9558
language English
publishDate 2024-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-f62cd29e0f684705b3c342fb136555422025-02-02T08:34:38ZengSciendoActa Pharmaceutica1846-95582024-09-0174347949310.2478/acph-2024-0022Alternative buffer systems in biopharmaceutical formulations and their effect on protein stabilityLebar Blaž0Zidar Mitja1Mravljak Janez2Šink Roman3Žula Aleš4Pajk Stane5University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, SI-1000Ljubljana SloveniaNovartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d.SI-1000Ljubljana, SloveniaUniversity of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, SI-1000Ljubljana SloveniaNovartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d.SI-1000Ljubljana, SloveniaNovartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d.SI-1000Ljubljana, SloveniaUniversity of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, SI-1000Ljubljana SloveniaThe formulation of biopharmaceutical drugs is designed to eliminate chemical instabilities, increase conformational and colloidal stability of proteins, and optimize interfacial stability. Among the various excipients involved, buffer composition plays a pivotal role. However, conventional buffers like histidine and phosphate buffers may not always be the optimal choice for all monoclonal antibodies (mAbs). In this study, we investigated the effects of several alternative buffer systems on seven different mAbs, exploring various combinations of ionic strengths, concentrations of the main buffer component, mAb concentrations, and stress conditions. Protein stability was assessed by analyzing soluble aggregate formation through size exclusion chromatography. At low protein concentrations, protein instability after temperature stress was exclusively observed in the bis-TRIS/ glucuronate buffer. Conversely, freeze-thaw stress led to a significant increase in aggregate formation in tested formulations, highlighting the efficacy of several alternative buffers, particularly arginine/ citrate, in preserving protein stability. Under temperature stress, the introduction of arginine to histidine buffer systems provided additional stabilization, while the addition of lysine resulted in protein destabilization. Similarly, the incorporation of arginine into histi-dine/HCl buffer further enhanced protein stability during freeze--thaw cycles. At high protein concentrations, the histidine/citrate buffer emerged as one of the most optimal choices for addressing temperature and light-induced stress. The efficacy of histidine buffers in combating light stress might be attributed to the light-absorbing properties of histidine molecules. Our findings demonstrate that the development of biopharmaceutical formulations should not be confined to conventional buffer systems, as numerous alternative options exhibit comparable or even superior performance.https://doi.org/10.2478/acph-2024-0022biopharmaceuticalsbufferstressaggregatesalternative buffersstability
spellingShingle Lebar Blaž
Zidar Mitja
Mravljak Janez
Šink Roman
Žula Aleš
Pajk Stane
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
Acta Pharmaceutica
biopharmaceuticals
buffer
stress
aggregates
alternative buffers
stability
title Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
title_full Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
title_fullStr Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
title_full_unstemmed Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
title_short Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
title_sort alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
topic biopharmaceuticals
buffer
stress
aggregates
alternative buffers
stability
url https://doi.org/10.2478/acph-2024-0022
work_keys_str_mv AT lebarblaz alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability
AT zidarmitja alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability
AT mravljakjanez alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability
AT sinkroman alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability
AT zulaales alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability
AT pajkstane alternativebuffersystemsinbiopharmaceuticalformulationsandtheireffectonproteinstability